MyFinsight
Home
Blog
About
Contact
Download
Download image
Net loss
-$14,909,754
(-64.93%↓ Y/Y)
Loss before income
tax expense
-$14,865,712
(-64.66%↓ Y/Y)
Income tax expense
$44,042
(278.04%↑ Y/Y)
Other income
$40,490
(292.23%↑ Y/Y)
Health Care Patient
Service
$4,971,342
(-39.19%↓ Y/Y)
Histology Service Fees
$1,116,912
(1.19%↑ Y/Y)
Medical Director Fees
$68,268
(2.54%↑ Y/Y)
Other Revenues
$4,860
(-34.07%↓ Y/Y)
Department Of Defense
Observational Studies
$577
(-93.33%↓ Y/Y)
Interest income
$23,385
(32.79%↑ Y/Y)
Loss from operations
-$10,572,508
(-18.08%↓ Y/Y)
Change in fair value of
warrants issued
$3,810,278
Other expense
$502,429
(4828.67%↑ Y/Y)
Net revenue
$6,161,959
(-34.18%↓ Y/Y)
Interest expense
$44,372
(-52.02%↓ Y/Y)
Total operating
expenses
$16,734,467
(-8.63%↓ Y/Y)
Selling, general and
administrative
$9,913,729
(-0.30%↓ Y/Y)
Direct costs and
expenses
$4,226,799
(-29.36%↓ Y/Y)
Research and development
$1,383,359
(-5.33%↓ Y/Y)
Clinical development
$705,744
(119.41%↑ Y/Y)
Depreciation and
amortization
$504,836
(-16.64%↓ Y/Y)
Back
Back
Income Statement
source: myfinsight.com
bioAffinity Technologies, Inc. (BIAF)
bioAffinity Technologies, Inc. (BIAF)